BIOFILCHEM

Biofil Chemicals & Pharmaceuticals Limited

Biofil Chemicals & Pharmaceuticals Limited (BIOFILCHEM) financial statements and selected valuation metrics through 30 June 2026.

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

biofilgroup.net(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹30.18
Market cap
49 Cr
Stock P/E
101.5
P/B
2.28
ROE (FY26)
12.9%
ROCE (FY26)
14.1%
Operating margin (FY26)
1.3%
Debt / equity (FY26)
0.14

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

Biofil Chemicals and Pharmaceuticals makes and trades pharmaceutical products and chemicals from Indore, Madhya Pradesh, reporting a Pharma Division and a Chemicals Division.

Company snapshot

117thBy market cap

Ranked among 119 companies in Pharmaceuticals.

Segment mix

Reportable segments as of 2024-12-31 (Standalone). Revenue share = segment revenue ÷ total revenue.

Largest segment: 84.9% of revenue

SegmentRevenue shareRevenuePBTAssets
Chemicals Division
15.1%
4 Cr0.58 Cr—
Pharma Unit
84.9%
21 Cr-0.07 Cr—

What we see

Positives
  • ✓Debt-to-equity of 0.14x — the company is largely funded by its own money, not borrowed funds.
1 more signal from the filings.Sign in free to see them all

Statement tables · Standalone

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Standalone only

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales17 Cr5 Cr15 Cr8 Cr2 Cr14 Cr8 Cr6 Cr14 Cr0.86 Cr8 Cr12 Cr
Operating expenses (approx.)17 Cr5 Cr15 Cr8 Cr2 Cr14 Cr8 Cr6 Cr13 Cr0.76 Cr7 Cr12 Cr
EBITDA0.24 Cr0.19 Cr-0.03 Cr0.31 Cr0.12 Cr0.31 Cr0.11 Cr0.0058 Cr0.11 Cr0.09 Cr0.43 Cr0.14 Cr
OPM %1.4%3.8%-0.2%3.6%5.2%2.2%1.3%0.1%0.8%11.1%5.7%1.1%
Other income0.03 Cr0.03 Cr0.41 Cr0.03 Cr0.02 Cr0.02 Cr0.24 Cr3 Cr0.06 Cr0.08 Cr0.11 Cr0.06 Cr
Interest0.0097 Cr0.0001 Cr0.02 Cr0.01 Cr0.0090 Cr0.0098 Cr0.0075 Cr0.0093 Cr0.0001 Cr0.0005 Cr0.0002 Cr0.0007 Cr
Depreciation0.11 Cr0.11 Cr0.08 Cr0.10 Cr0.10 Cr0.10 Cr0.08 Cr0.07 Cr0.07 Cr0.07 Cr0.07 Cr0.07 Cr
Profit before tax0.15 Cr0.11 Cr0.27 Cr0.23 Cr0.03 Cr0.22 Cr0.25 Cr3 Cr0.11 Cr0.11 Cr0.47 Cr0.13 Cr
Tax %19.6%17.7%9.5%25.7%25.6%25.8%21.4%12.7%25.2%25.8%54.7%18.6%
Net profit0.12 Cr0.09 Cr0.25 Cr0.17 Cr0.02 Cr0.16 Cr0.20 Cr2 Cr0.08 Cr0.08 Cr0.21 Cr0.11 Cr
EPS (₹)₹0.08₹0.06₹0.15₹0.10₹0.01₹0.10₹0.12₹1.48₹0.05₹0.05₹0.13₹0.07

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales13 Cr12 Cr23 Cr30 Cr36 Cr22 Cr30 Cr40 Cr33 Cr28 CrSign in free for the trailing twelve months
Operating expenses (approx.)11 Cr11 Cr22 Cr28 Cr34 Cr21 Cr29 Cr39 Cr33 Cr28 CrSign in free for the trailing twelve months
EBITDA3 Cr0.93 Cr1 Cr2 Cr2 Cr1 Cr1 Cr0.82 Cr0.85 Cr0.65 CrSign in free for the trailing twelve months
OPM %19.5%7.6%4.4%6.1%4.5%6.0%3.9%2.0%2.5%2.3%Sign in free for the trailing twelve months
Other income0.14 Cr0.10 Cr0.10 Cr0.17 Cr0.80 Cr0.15 Cr0.10 Cr0.49 Cr0.31 Cr3 CrSign in free for the trailing twelve months
Interest0.16 Cr0.15 Cr0.16 Cr0.12 Cr0.07 Cr0.04 Cr0.04 Cr0.04 Cr0.04 Cr0.01 CrSign in free for the trailing twelve months
Depreciation0.28 Cr0.30 Cr0.37 Cr0.41 Cr0.41 Cr0.43 Cr0.43 Cr0.40 Cr0.38 Cr0.27 CrSign in free for the trailing twelve months
Profit before tax2 Cr0.59 Cr0.60 Cr1 Cr2 Cr1 Cr0.79 Cr0.87 Cr0.74 Cr3 CrSign in free for the trailing twelve months
Tax %22.3%20.0%19.4%17.5%35.2%31.2%29.3%18.0%24.2%19.2%Sign in free for the trailing twelve months
Net profit2 Cr0.47 Cr0.48 Cr1 Cr1 Cr0.70 Cr0.56 Cr0.71 Cr0.56 Cr3 CrSign in free for the trailing twelve months
EPS (₹)₹1.10₹0.29₹0.30₹0.76₹0.76₹0.44₹0.29₹0.44₹0.34₹1.71Sign in free for the trailing twelve months
Dividend payout %————0.0%0.0%0.0%0.0%0.0%0.0%Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital16 Cr16 Cr16 Cr16 Cr16 Cr16 Cr16 Cr16 Cr16 Cr16 Cr
Reserves-4 Cr-3 Cr-3 Cr-1 Cr-0.14 Cr0.56 Cr1 Cr2 Cr3 Cr5 Cr
Borrowings1 Cr2 Cr2 Cr1 Cr0.43 Cr0.46 Cr0.52 Cr0.44 Cr0.47 Cr3 Cr
Other liabilities8 Cr9 Cr9 Cr26 Cr17 Cr1 Cr14 Cr28 Cr32 Cr18 Cr
Total liabilities22 Cr24 Cr24 Cr42 Cr33 Cr19 Cr31 Cr47 Cr51 Cr43 Cr
Fixed assets (net)9 Cr9 Cr10 Cr10 Cr10 Cr9 Cr9 Cr9 Cr8 Cr7 Cr
CWIP——0 Cr—0 Cr—————
Investments——0 Cr0 Cr0 Cr0 Cr0 Cr0 Cr0 Cr0 Cr
Inventories0.17 Cr1 Cr1 Cr2 Cr4 Cr1 Cr1 Cr3 Cr3 Cr4 Cr
Trade receivables11 Cr13 Cr12 Cr30 Cr17 Cr7 Cr21 Cr33 Cr38 Cr28 Cr
Cash & bank0.31 Cr0.37 Cr0.06 Cr0.18 Cr0.0097 Cr0.09 Cr0.03 Cr0.09 Cr0.13 Cr0.06 Cr
Other assets0.74 Cr0.53 Cr0.65 Cr0.69 Cr2 Cr0.76 Cr0.66 Cr3 Cr0.83 Cr4 Cr
Total assets22 Cr24 Cr24 Cr42 Cr33 Cr19 Cr31 Cr47 Cr51 Cr43 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity0.71 Cr0.46 Cr10 Cr1 Cr1 Cr-0.22 Cr-0.11 Cr2 Cr-2 Cr-0.60 Cr
Cash from investing-0.48 Cr-0.38 Cr-1 Cr-0.21 Cr-0.10 Cr-0.07 Cr-0.01 Cr-0.02 Cr-0.10 Cr1 Cr
Cash from financing-0.10 Cr-0.02 Cr-0.08 Cr-0.57 Cr-0.83 Cr-0.0058 Cr0.02 Cr-0.12 Cr-0.0045 Cr3 Cr
Net cash flow0.13 Cr0.06 Cr8 Cr0.27 Cr0.18 Cr-0.30 Cr-0.11 Cr2 Cr-2 Cr3 Cr
Free cash flow (OCF − Capex)0.19 Cr0.09 Cr8 Cr0.84 Cr0.54 Cr-0.29 Cr-0.12 Cr2 Cr-2 Cr-0.81 Cr

Ratios

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %17.5%5.0%5.0%9.9%12.0%6.1%4.7%4.9%4.0%14.1%
ROE %14.1%3.6%3.5%8.1%7.8%4.1%3.2%3.9%3.0%12.9%
Debtor days310382189365175117248301418354
Inventory days67480561152231208113177229197
Days payable285742804043234384296117519132122841
Cash conversion cycle-2479-3418-3293-1826-436229-814-1435-1476-290
OCF / EBITDA %27.2%49.6%930.2%57.2%69.2%-16.5%-9.6%n.m.n.m.n.m.
OCF / EBITDA % (3 years)——233.5%291.5%262.3%40.6%18.9%62.2%n.m.n.m.
Debt / equity0.110.120.120.080.030.030.030.020.030.14
Current ratio1.391.361.321.171.406.231.631.351.341.73
Net debt / EBITDA0.431.271.550.560.260.280.430.420.404.55